JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2001; 38:111-116
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lundman, P.
Right arrow Articles by Tornvall, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lundman, P.
Right arrow Articles by Tornvall, P.

CLINICAL STUDY

Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine

Pia Lundman, MDa{ddagger} §, Maria J. Eriksson, MD, PhD{dagger}, Markus Stühlinger, MD||, John P. Cooke, MD, PhD||, Anders Hamsten, MD, PhDa{ddagger} and Per Tornvall, MD, PhDa{ddagger}

a Department of Cardiology, Karolinska Institutet, Stockholm, Sweden
{dagger} Department of Clinical Physiology, Karolinska Institutet, Stockholm, Sweden
{ddagger} Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institutet, Stockholm, Sweden
§ Department of Medicine, Danderyd Hospital, Stockholm, Sweden
|| Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California, USA

Manuscript received November 7, 2000; revised manuscript received March 9, 2001, accepted March 26, 2001.

Reprint requests and correspondence: Dr. Pia Lundman, Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Hospital, SE-171 76 Stockholm, Sweden
Pia.Lundman{at}medks.ki.se


   Abstract
Top
 Abstract
Methods
 Results
 Discussion
 References
 
OBJECTIVES

The aim of this study was to investigate endothelial function and common carotid intima-media thickness (IMT) in healthy young men with mild-to-moderate hypertriglyceridemia. Plasma asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, was measured to further elucidate the mechanisms involved.

BACKGROUND

Hypertriglyceridemia is a risk factor for coronary heart disease although the mechanisms behind the increased risk remain to be defined. Acute elevation of plasma triglycerides induced by an intravenous fat load is associated with impaired endothelial function. The results of studies examining acute effects induced by a high-fat meal or effects of chronic hypertriglyceridemia on endothelial function are more inconsistent.

METHODS

Flow-mediated vasodilation and nitroglycerin-induced vasodilation of the brachial artery and common carotid IMT were measured noninvasively by ultrasound technique in 15 hypertriglyceridemic (HTG) subjects and 15 matched controls, mean age 34 years. Plasma concentrations of ADMA were measured by high-performance liquid chromatography.

RESULTS

Flow-mediated vasodilation was decreased in the HTG group (p < 0.0001), whereas nitroglycerin-induced vasodilation and carotid IMT did not differ significantly. Asymmetric dimethylarginine concentrations were higher in the HTG group (p < 0.05).

CONCLUSIONS

Hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentration of ADMA but not with increased IMT of the common carotid artery. The corollary is that chronic hypertriglyceridemia results in endothelial dysfunction, possibly due to increased ADMA concentration, and that endothelial dysfunction might precede increased IMT among the early manifestations of atherosclerosis.

Abbreviations and Acronyms
  ADMA = asymmetric dimethylarginine
  BMI = body mass index
  CHD = coronary heart disease
  FFA = free fatty acids
  FMD = flow-mediated vasodilation
  HDL = high-density lipoprotein
  HTG = hypertriglyceridemic
  IMT = intima-media thickness
  LDL = low-density lipoprotein
  LPL = lipoprotein lipase
  NTG = nitroglycerin
  VLDL = very low-density lipoprotein

Hypertriglyceridemia is a risk factor for coronary heart disease (CHD) although the biological mechanisms behind the increased risk remain to be properly defined (1). For instance, it is unclear whether atherogenic or thrombogenic factors are involved or a combination thereof. Endothelial dysfunction and increased common carotid intima-media thickness (IMT) are both early features of atherosclerosis (2–4). Common risk factors for CHD, such as age, smoking, hypertension, hypercholesterolemia and diabetes mellitus are associated with impaired endothelium-dependent vasodilation (5–9), which supports a pathogenic role of endothelial dysfunction in atherosclerosis. Patients with manifest CHD have impaired endothelium-dependent vasodilation in brachial as well as in coronary arteries, with a close correlation between the two sites, indicating a systemic nature of endothelial dysfunction (10,11). Several risk factors for CHD are also associated with increased carotid IMT (12,13), and it has been shown that IMT measures correlate with endothelial function (14). Carotid IMT measured by high-resolution ultrasound imaging technique is increasingly used as a marker of early atherosclerosis, and it is associated with the degree of coronary artery disease (15,16).

In a previous study of healthy young men, we showed that endothelium-dependent flow-mediated dilation (FMD), measured by ultrasound of the brachial artery, decreased after experimental triglyceridemia produced by infusion of a triglyceride-rich fat emulsion (17), whereas data regarding FMD after a high-fat meal are inconclusive (18,19). Data regarding endothelial function in chronic hypertriglyceridemia are also inconsistent. Chowienczyk et al. (20) showed in 1997 that patients with severe hypertriglyceridemia, due to low lipoprotein lipase (LPL) activity, have normal pharmacologically stimulated endothelium-dependent vasodilation, as assessed by forearm venous occlusion plethysmography (20). More recently, two studies using the same technique have shown that moderate (21) and severe hypertriglyceridemia, but with normal LPL activity (22), are associated with impaired endothelium-dependent vasodilation. Two studies have hitherto been performed to noninvasively investigate effects of chronic hypertriglyceridemia on endothelial function using FMD of the brachial artery with conflicting results (23,24). Whether hypertriglyceridemia is accompanied by increased IMT, on the other hand, has not been extensively studied, and no such studies have been performed in young men with mild-to-moderate hypertriglyceridemia.

This study was conducted to investigate the relations between chronic mild-to-moderate hypertriglyceridemia in young men and two markers of early atherosclerosis. To the best of our knowledge, this is the first study that has simultaneously investigated FMD of the brachial artery and common carotid IMT in relation to a risk factor for atherosclerosis. Since the young hypertriglyceridemic (HTG) men showed impaired FMD, the plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, were also measured to further elucidate the mechanisms behind endothelial dysfunction in hypertriglyceridemia.


   Methods
Top
 Abstract
 Methods
Results
 Discussion
 References
 
Subjects.   Healthy men under the age of 40 years with a fasting plasma triglyceride concentration between 3 mmol/l and 10 mmol/l and a fasting plasma cholesterol concentration below 6.5 mmol/l were invited to participate in the study. They were identified in a screening program directed towards employees of private companies in the Stockholm metropolitan area. Healthy male controls matched for age and body mass index (BMI) who had fasting plasma concentrations of triglyceride below 1.6 mmol/l and cholesterol below 6.5 mmol/l were recruited among hospital staff and volunteering friends. Two of the volunteering controls were found to be HTG and were included in the HTG group. All participants had to be normoglycemic (fasting plasma glucose <6.2 mmol/l) and normotensive with a systolic blood pressure below 140 mm Hg and a diastolic blood pressure below 90 mm Hg. Further exclusion criteria were smoking, excessive alcohol consumption, any current medication and a family history of premature CHD.

Study protocol.   Fifteen HTG and 15 control subjects were finally included in the study. Because of the day-to-day variation in plasma triglycerides and FMD, all subjects were examined on two separate occasions within one week. The participants arrived in the laboratory the morning after an overnight fast. They were placed in a supine position in a quiet darkened room with a temperature of 22°C to 23°C before venous blood was collected. Ultrasound imaging of the left and right common carotid arteries was followed by ultrasound measurement of the left brachial artery, performed according to protocols described below. All ultrasound scans and images were recorded on videotapes.

The Ethics Committee of the Karolinska Hospital approved the study, and all subjects gave their informed consent to participate.

Blood sampling and lipid, free fatty acid (FFA), insulin and ADMA determinations.   Venous blood was drawn into vacutainer tubes containing 1.4 mg Na2EDTA/ml and instantly put into ice water. Plasma was recovered after low-speed centrifugation (1.750 g, 20 min, +4°C). Samples for analyses of glucose, insulin, FFA and ADMA were immediately frozen at –20°C and then transferred to –70°C. On thawed samples, determinations were made of plasma glucose concentrations by chemical methods (Vitros, Johnson & Johnson AB, Sollentuna, Sweden) and of plasma insulin and FFA concentrations by enzymatic methods (DAKO insulin, DAKO Diagnostics Ltd, Cambridgeshire, United Kingdom and NEFA C, Wako Chemicals GmBH, Neuss, Germany). Frozen plasma samples were transported on dry ice to Stanford University, Stanford, California, where plasma concentrations of ADMA were measured on thawed samples by high-performance liquid chromatography, as described (25). The recovery rate for ADMA was 84%, and the coefficient of variation was 3.5%. The detection limit of the assay was 0.1 µmol/l.

Concentrations of cholesterol and triglycerides in very low-density lipoprotein (VLDL), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) fractions were determined in fresh plasma by a combination of preparative ultracentrifugation and precipitation of apo B-containing lipoproteins followed by lipid analyses (26). Cholesterol and triglyceride concentrations were determined by enzymatic methods (Triglycerides/GB, Boehringer Mannheim Corp, Indiana, and Unimate 5 Chol, Triolab, Mölndal, Sweden).

Endothelial function.   Brachial artery flow velocity, endothelium-dependent FMD and endothelium-independent nitroglycerin (NTG)-induced dilation were examined according to the method described by Celermajer et al. (5). The measurements were made noninvasively using a high-resolution ultrasound scanner (Acuson 128 XP/10 c, Mountain View, California) with a 7-MHz linear array transducer. Baseline measurements of blood flow and inner diameter of the artery were performed at rest. Reactive hyperemia was obtained by distal forearm artery occlusion with a 12.5-cm blood pressure cuff at the wrist inflated to 300 mm Hg for 4.5 min. Blood velocity was measured immediately after cuff release, and the inner diameter of the artery was measured 50 to 60 s after deflation. New inner diameter measurement was performed after a 10-min rest followed by administration of 0.4-mg sublingual NTG. After 4 min, blood velocity and inner diameter measurements were repeated. All analyses of the inner diameters of the brachial artery were performed by one investigator who was blinded to the identity of the subject, date and sequence of the ultrasound scan. Four sequential diastolic frames taken coincidentally with the R wave on the electrocardiogram were analyzed at rest and after each stimulation, and the average diameter of the four frames was calculated. Blood flow was calculated from Doppler velocity, vessel diameter and heart rate. The increase in blood flow after reactive hyperemia is presented as a percentage of basal flow values. In the control subjects, the variation in differences between FMD measurements performed within one week was 2.3 ± 2.5%. The within-individual variations between two determinations of FMD performed during the same day and between three determinations made on separate days in our laboratory are 0.88 ± 0.82% and 3.3 ± 2.7%, respectively, as previously reported (17).

Common carotid IMT.   The IMT of both common carotid arteries was measured using the same ultrasound scanner and a similar transducer as for endothelial function measurements. The common carotid arteries were scanned to the level of the bulb, and the far wall thickness was measured over a length of 1 cm just proximal to the carotid bulb. The IMT was defined as the distance between the leading edge of the luminal echo to the leading edge of the media/adventitia echo (26). A frozen longitudinal image, synchronized to the top of the R-wave on the electrocardiogram, was recorded on videotape and later transferred to an automated computerized analysis system (Dept. of Signal and Systems, Chalmers University of Technology, Göteborg, Sweden). It has previously been shown that this system reduces the variability of the ultrasound measurements of IMT (27–29). The echo structures of the ultrasound image were automatically detected and IMT and vessel diameter measured by the computer. One experienced reader who was unaware of the case control status of the subjects performed all measurements. The coefficient of variation of duplicate IMT measurements in control subjects performed within one week were 3.2% and 3.3% for the right and left common carotid artery, respectively. The IMT is presented as the mean value of the left and right common carotid artery IMT.

Statistical methods.   Group distributions are expressed as mean ± SD of two determinations. The coefficients of variation were calculated according to standard methods. Statistical testing of differences in continuous variables between groups were made by Student unpaired t test for normally distributed variables and by Mann-Whitney U test for triglycerides, VLDL triglycerides, HDL cholesterol, insulin and ADMA. A p value <0.05 was considered significant.


   Results
Top
 Abstract
 Methods
 Results
Discussion
 References
 
Subjects and biochemical data.   The clinical and biochemical characteristics of the studied subjects are presented in Table 1. Hypertriglyceridemic and normotriglyceridemic control subjects were well matched for age and BMI. There were no differences in systolic and diastolic blood pressures, glucose, FFA or LDL cholesterol concentrations. Subjects with hypertriglyceridemia had significantly higher VLDL triglyceride and insulin concentrations and lower HDL cholesterol concentration than controls. Hypertriglyceridemic subjects had higher plasma ADMA concentration than normotriglyceridemic control subjects (Table 1).


View this table:
[in this window]
[in a new window]
  		Table 1 Clinical and Biochemical Characteristics of the Study Groups

 
Brachial artery determinations.   The baseline diameters of the brachial artery were similar in HTG and control subjects (4.12 mm ± 0.40 mm vs. 4.17 mm ± 0.44 mm, NS), and there was a similar increase of blood flow after reactive hyperemia in both groups (500 ± 93% vs. 570 ± 130%, NS). Flow-mediated dilation was decreased in HTG subjects compared with controls (0.6 ± 0.8% vs. 4.5 ± 2.0%, p < 0.0001) (Fig. 1). In contrast, there was no difference in NTG-induced vasodilation (16.4 ± 2.6% vs. 17.5 ± 6.2%, NS).



View larger version (12K):
[in this window]
[in a new window]
  		Figure 1 Box plots of relative change in endothelium-dependent flow-mediated vasodilation (FMD) after reactive hyperemia in hypertriglyceridemic (HTG) (n = 15) and control (n = 15) subjects (0.6 ± 0.83% vs. 4.5 ± 2.0%, p < 0.0001). The box plot displays 25th, 50th (median) and 75th percentiles in the box and 5th and 95th percentiles as horizontal lines outside the box. All values above or below these percentiles are plotted as points.

 
Common carotid measurements.   The diameters of the common carotid arteries were similar in the two groups. In HTG subjects, the diameter was 6.29 mm ± 0.58 mm on the right side and 6.15 mm ± 0.47 mm on the left side. The corresponding diameters in the control subjects were 6.34 mm ± 0.38 mm and 6.19 mm ± 0.39 mm, respectively. The mean IMT of the far wall of the right and left common carotid arteries was 0.55 mm ± 0.05 mm in HTG subjects compared with 0.53 mm ± 0.06 mm in control subjects (NS, Fig. 2). There were, likewise, no differences between the two groups when the IMTs of the left and right sides were analyzed separately.



View larger version (15K):
[in this window]
[in a new window]
  		Figure 2 Box plots of common carotid intima-media thickness (IMT) in hypertriglyceridemic (HTG) (n = 15) and control (n = 15) subjects (0.55 ± 0.05 mm vs. 0.53 ± 0.06 mm, NS). The box plot displays 25th, 50th (median) and 75th percentiles in the box and 5th and 95th percentiles as horizontal lines outside the box. All values above or below these percentiles are plotted as points.

 

   Discussion
Top
 Abstract
 Methods
 Results
 Discussion
References
 
The results of this study show that chronic mild-to-moderate hypertriglyceridemia in young men is associated with impaired endothelium-dependent vasodilation measured as FMD of the brachial artery but not with increased IMT of the common carotid artery. This suggests that hypertriglyceridemia is associated with premature atherosclerosis and that FMD of the brachial artery might be a more sensitive measurement of early atherosclerosis than common carotid IMT.

Hypertriglyceridemia and endothelial function.   The results of earlier studies of endothelial function in chronic hypertriglyceridemia are inconsistent. In the study by Chowienczyk et al. (20), patients with severe hypertriglyceridemia and low LPL activity had normal pharmacologically stimulated endothelium-dependent vasodilation examined by forearm venous occlusion plethysmography. In contrast, two more recent studies using the same technique have demonstrated an impaired endothelium-dependent vasodilation in subjects with either moderate (21) or severe hypertriglyceridemia and normal LPL activity (22). Two studies have been published so far using FMD measured by ultrasound of the brachial artery for assessment of endothelial function. Lupattelli et al. (24) showed that chronic hypertriglyceridemia was associated with impaired endothelium-dependent vasodilation, whereas Schnell et al. (23) failed to show a difference between cases and controls. The reason for the discrepant results of the previous studies in chronic hypertriglyceridemia is not easily discernible. One possible explanation could be the different techniques used, including the mode of stimulation.

Two important design features differed between this study and that of Schnell and coworkers (23). In the study by Schnell, the two hyperlipidemic groups and the control group contained a fairly large proportion of premenopausal women whose positions in the menstruation cycle at the time of the study were unknown. Secondly, the hyperlipidemic groups were older than the controls. Surprisingly, despite the difference in age, there were no differences in endothelium-dependent vasodilation, neither between the HTG subjects and the control group nor between the hypercholesterolemic individual and the control group. Of note is that previous studies have consistently shown that hypercholesterolemia is associated with endothelial dysfunction (5–7,30).

HDL.   There was an expected difference in HDL cholesterol concentration between HTG subjects and controls since increased VLDL triglycerides are strongly associated with low HDL cholesterol (31). It, therefore, cannot be concluded with certainty that the endothelial dysfunction seen in this study is due to hypertriglyceridemia. Previous studies have demonstrated that the HDL cholesterol concentration is related to endothelial function (32,33). However, in the study by Toikka et al. (33), which showed that a decreased HDL cholesterol concentration is associated with endothelial dysfunction, the two groups were neither matched for plasma triglyceride nor for LDL cholesterol concentrations, which differed significantly. To properly assess the impact of HDL on endothelial function in vivo, subjects with different HDL cholesterol concentrations, but matched for plasma triglyceride and LDL cholesterol concentrations, need to be examined.

In this study, correlations were found between both VLDL triglyceride and HDL cholesterol concentrations on the one hand and FMD of the brachial artery on the other (data not shown). Due to the selection criterion for participation in the present case-control study, presence or absence of hypertriglyceridemia, no further conclusions can be drawn from multivariate analysis.

Common carotid IMT.   In our study we also examined the common carotid IMT to further assess early stages of atherosclerosis. Several observations justify the use of this surrogate measurement. Increased IMT is associated with established risk factors for CHD (12,13) and correlates with the severity of coronary artery disease (15,16). There is a paucity of studies of IMT in hypertriglyceridemia. Karpe et al. (34) demonstrated that middle-aged men with hypertriglyceridemia have an increased IMT compared with healthy normolipidemic controls, and studies of postprandial triglyceridemia have shown correlation between the response to a high-fat meal and IMT, independently of other risk factors for CHD (35,36). Furthermore, Grønholdt et al. (37) found that an increased lipid content in carotid plaques, as demonstrated by ultrasound technique, is associated with increased fasting and postprandial plasma triglyceride concentrations. Since hypertriglyceridemia was associated with endothelial dysfunction, which is a marker of early atherosclerosis and possibly also mechanistically implicated in atherogenesis, we suggest that hypertriglyceridemia is a proatherogenic state. No difference in IMT was seen between cases and controls, and it can, therefore, be speculated that endothelial dysfunction might be an earlier feature of atherosclerosis than increased IMT.

ADMA.   The HTG subjects had higher plasma concentrations of the endogenous nitric oxide synthase inhibitor ADMA than the control subjects. Increased concentrations of ADMA have been shown to be associated with decreased nitric oxide production and with decreased endothelium-dependent FMD in hypercholesterolemic patients (25). The plasma concentration of ADMA is also increased in patients with other risk factors for CHD (38) and in peripheral arterial disease (39), and it is associated with carotid IMT (40). Furthermore, in patients with type 2 diabetes mellitus, it has recently been shown that ADMA levels increase in response to a high-fat meal, accompanied by impaired FMD (41). The biological mechanisms behind the increased ADMA concentrations are not yet fully understood, but reduced degradation of ADMA may be involved in its accumulation in hyperlipidemia (38). Asymmetric dimethyl-arginine plays an important role in the regulation of nitric oxide bioavailability and has been suggested to be a novel marker of atherosclerosis.

Conclusions.   Hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentration of ADMA but not with increased IMT of the common carotid artery. We suggest that chronic hypertriglyceridemia results in endothelial dysfunction, possibly due to increased ADMA concentrations and that endothelial dysfunction might precede increased IMT among the early manifestations of atherosclerosis.


   Footnotes
 
Supported by the Swedish Heart Lung Foundation, the Swedish Medical Research Council (8691) and the Serafimer Hospital Foundation, Sweden. The National Heart, Lung and Blood Institute (RO1 HL58638) and the Tobacco Related Diseases Research Program, U.S. Dr. Cooke is an Established Investigator of the American Heart Association. Dr. Stühlinger is a recipient of an "Erwin Schrödinger Auslandsstipendium" provided by the Austrian "Fonds zur Förderung der wissenschaftlichen Forschung" (J1893-MED).


   References
Top
 Abstract
 Methods
 Results
 Discussion
 References
 

  1. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B–12B[CrossRef][Medline]
  2. Zeiher AM, Schächinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Circulation. 1994;89:2525–2532[Abstract/Free Full Text]
  3. Lieberman EH, Gerhard MD, Uehata A, et al. Flow-induced vasodilatation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol. 1996;78:1210–1214[CrossRef][Medline]
  4. Pignoli P, Tremoli E, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399–1406[Abstract/Free Full Text]
  5. Celermajer DS, Sorensen KE, Gooch VM, et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111–1115[CrossRef][Medline]
  6. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24:1468–1474[Abstract]
  7. Reddy KG, Nair RN, Sheehan HM, Hodgson JMcB. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994;23:833–43.
  8. Watts GF, O’Brien SF, Silvester W, Millar JA. Impaired endothelium-dependent and independent dilation of forearm resistance arteries in men with diet-treated noninsulin-dependent diabetes: role of dyslipidaemia. Clin Sci. 1996;91:567–573[Medline]
  9. Williams SB, Cusco JA, Roddy M-A, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with noninsulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567–574[Abstract]
  10. Anderson TJ, Gerhard MD, Meredith IT, et al. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995;75:71B–74B[CrossRef][Medline]
  11. Neunteufl T, Katzenschlager R, Hassan A, et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis. 1997;129:111–118[CrossRef][Medline]
  12. Salonen R, Tervahauta M, Salonen JT, Pekkanen J, Nissinen MJ. Ultrasonographic manifestations of common carotid atherosclerosis in elderly Finnish men. Prevalence and associations with cardiovascular diseases and risk factors. Arterioscler Thromb. 1994;10:1631–1640
  13. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk In Communities (ARIC) study, 1987 to 1993. Am J Epidemiol. 1997;146:483–494[Abstract/Free Full Text]
  14. Hashimoto M, Eto M, Akishita M, et al. Correlation between flow-mediated vasodilation of the brachial artery and intima-media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol. 1999;19:2795–2800[Abstract/Free Full Text]
  15. Craven TE, Ryu JE, Espeland MA, et al. Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. Circulation. 1990;82:1230–1242[Abstract/Free Full Text]
  16. Davis PH, Dawson JD, Mahoney LT, Lauer RM. Increased carotid intimal-medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study. Circulation. 1999;100:838–842[Abstract/Free Full Text]
  17. Lundman P, Eriksson M, Schenck-Gustafsson K, Karpe F, Tornvall P. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation. 1997;96:3266–3268[Abstract/Free Full Text]
  18. Vogel RA, Coretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol. 1997;79:350–354[CrossRef][Medline]
  19. Raitakari OT, Lai N, Griffiths K, McCredie R, Sullivan D, Celermajer DS. Enhanced peripheral vasodilation in humans after a fatty meal. J Am Coll Cardiol. 2000;36:417–422[Abstract/Free Full Text]
  20. Chowienczyk PJ, Watts GF, Wierzbicki AS, Cockcroft JR, Brett SE, Ritter J. Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. J Am Coll Cardiol. 1997;29:964–968[Abstract]
  21. Lewis TW, Dart AM, Chin-Dusting JPF. Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol. J Am Coll Cardiol. 1999;33:805–812[Abstract/Free Full Text]
  22. de Man FH, Weverling-Rijnsburger AWE, van der Laarse A, Smelt AHM, Jukema JW, Blauw GJ. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation. Arterioscler Thromb Vasc Biol. 2000;20:744–750[Abstract/Free Full Text]
  23. Schnell GB, Robertson A, Houston D, Malley L, Anderson TJ. Impaired brachial artery endothelial function is not predicted by elevated triglycerides. J Am Coll Cardiol. 1999;33:2038–2043[Abstract/Free Full Text]
  24. Lupattelli G, Lombardini R, Schillaci G, et al. Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles. Am Heart J. 2000;140:521–526[CrossRef][Medline]
  25. Böger RH, Bode-Böger SM, Szuba A, et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction—its role in hypercholesterolemia. Circulation. 1998;98:1842–1847[Abstract/Free Full Text]
  26. Carlson K. Lipoprotein fraction action. J Clin Pathol. 1973;5:32–37
  27. Wendelhag I, Gustavsson T, Suurkula M, Berglund G, Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol. 1991;11:565–577[Medline]
  28. Gustavsson T, Liang Q, Wendelhag I, Wikstrand J. A dynamic programming procedure for automated ultrasonic measurement of the carotid artery. IEEE Comput Cardiol. 1994;:297–300
  29. Wendelhag I, Liang Q, Gustavsson T, Wikstrand J. A new automated computerized analyzing system simplifies readings and reduces the variability in ultrasound measurement of intima-media thickness. Stroke. 1997;28:2195–2200[Abstract/Free Full Text]
  30. Steinberg HO, Bayazeed B, Hook G, Johnson A, Cronin J, Baron AD. Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans. Circulation. 1997;96:3287–3293[Abstract/Free Full Text]
  31. Tornvall P, Karpe F, Proudler A, et al. High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease. Metabolism. 1996;45:1375–1382[CrossRef][Medline]
  32. Kuhn FE, Mohler ER, Satler LF, Reagan K, Lu DY, Rackley CE. Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. Am J Cardiol. 1991;68:1425–1430[CrossRef][Medline]
  33. Toikka JO, Ahotupa M, Viikari JSA, et al. Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. Atherosclerosis. 1999;147:133–138[CrossRef][Medline]
  34. Karpe F, de Faire U, Mercuri M, Bond GM, Hellénius M-L, Hamsten A. Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men. Atherosclerosis. 1998;141:307–314[CrossRef][Medline]
  35. Ryu JE, Howard G, Craven TE, Bond MG, Hagaman AP, Crouse JR III. Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke. 1992;23:823–828[Abstract/Free Full Text]
  36. Boquist S, Ruotolo G, Tang R, et al. Alimetary lipemia, postprandial triglyceride-rich lipoproteins and common carotid intima-media thickness in healthy, middle-aged men. Circulation. 1999;100:723–728[Abstract/Free Full Text]
  37. Grønholdt M-LM, Nordestgaard B, Wiebe BM, Wilhjelm JE, Sillesen H. Echo-lucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content. Circulation. 1998;97:34–40[Abstract/Free Full Text]
  38. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol. 2000;20:2032–2037[Abstract/Free Full Text]
  39. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Froehlich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation. 1997;95:2068–2074[Abstract/Free Full Text]
  40. Miyazaki H, Matsuoka H, Cooke JP, et al. Endogenous nitric oxide synthase inhibitor—a novel marker of atherosclerosis. Circulation. 1999;99:1141–1146[Abstract/Free Full Text]
  41. Fard A, Tuck CH, Donis JA, et al. Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol. 2000;20:2039–2044[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
L. Wang, A. R. Sapuri-Butti, H. H. Aung, A. N. Parikh, and J. C. Rutledge
Triglyceride-rich lipoprotein lipolysis increases aggregation of endothelial cell membrane microdomains and produces reactive oxygen species
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H237 - H244.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Leong, D. Zylberstein, I. Graham, L. Lissner, D. Ward, J. Fogarty, C. Bengtsson, C. Bjorkelund, D. Thelle, and for The Swedish-Irish-Norwegian (SIN) Collaboratio
Asymmetric Dimethylarginine Independently Predicts Fatal and Nonfatal Myocardial Infarction and Stroke in Women: 24-Year Follow-Up of the Population Study of Women in Gothenburg
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 961 - 967.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
F. Bamberg, N. Dannemann, M. D. Shapiro, S. K. Seneviratne, M. Ferencik, J. Butler, W. Koenig, K. Nasir, R. C. Cury, A. Tawakol, et al.
Association Between Cardiovascular Risk Profiles and the Presence and Extent of Different Types of Coronary Atherosclerotic Plaque as Detected by Multidetector Computed Tomography
Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 568 - 574.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. Heutling, H. Schulz, I. Nickel, J. Kleinstein, P. Kaltwasser, S. Westphal, F. Mittermayer, M. Wolzt, K. Krzyzanowska, H. Randeva, et al.
Asymmetrical Dimethylarginine, Inflammatory and Metabolic Parameters in Women with Polycystic Ovary Syndrome before and after Metformin Treatment
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 82 - 90.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
F. Palm, M. L. Onozato, Z. Luo, and C. S. Wilcox
Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3227 - H3245.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Juonala, J. S.A. Viikari, G. Alfthan, J. Marniemi, M. Kahonen, L. Taittonen, T. Laitinen, and O. T. Raitakari
Brachial Artery Flow-Mediated Dilation and Asymmetrical Dimethylarginine in the Cardiovascular Risk in Young Finns Study
Circulation, September 18, 2007; 116(12): 1367 - 1373.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
T. K Rudolph, K. Ruempler, E. Schwedhelm, J. Tan-Andresen, U. Riederer, R. H Boger, and R. Maas
Acute effects of various fast-food meals on vascular function and cardiovascular disease risk markers: the Hamburg Burger Trial
Am. J. Clinical Nutrition, August 1, 2007; 86(2): 334 - 340.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. Krzyzanowska, F. Mittermayer, M. Wolzt, and G. Schernthaner
Asymmetric Dimethylarginine Predicts Cardiovascular Events in Patients With Type 2 Diabetes
Diabetes Care, July 1, 2007; 30(7): 1834 - 1839.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. Konishi, K. Sydow, and J. P. Cooke
Dimethylarginine Dimethylaminohydrolase Promotes Endothelial Repair After Vascular Injury
J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1099 - 1105.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. Meinitzer, U. Seelhorst, B. Wellnitz, G. Halwachs-Baumann, B. O. Boehm, B. R. Winkelmann, and W. Marz
Asymmetrical Dimethylarginine Independently Predicts Total and Cardiovascular Mortality in Individuals with Angiographic Coronary Artery Disease (The Ludwigshafen Risk and Cardiovascular Health Study)
Clin. Chem., February 1, 2007; 53(2): 273 - 283.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
F. Mittermayer, K. Krzyzanowska, M. Exner, W. Mlekusch, J. Amighi, S. Sabeti, E. Minar, M. Muller, M. Wolzt, and M. Schillinger
Asymmetric Dimethylarginine Predicts Major Adverse Cardiovascular Events in Patients With Advanced Peripheral Artery Disease
Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2536 - 2540.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
I. O. Ottestad, B. Halvorsen, T. R. Balstad, K. Otterdal, G. I. Borge, F. Brosstad, A. M. Myhre, L. Ose, M. S. Nenseter, and K. B. Holven
Triglyceride-Rich HDL3 from Patients with Familial Hypercholesterolemia Are Less Able to Inhibit Cytokine Release or to Promote Cholesterol Efflux
J. Nutr., April 1, 2006; 136(4): 877 - 881.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
K. Esposito and D. Giugliano
Diet and inflammation: a link to metabolic and cardiovascular diseases
Eur. Heart J., January 1, 2006; 27(1): 15 - 20.
[Abstract] [Full Text] [PDF]

Home page
 Vasc MedHome page
R. K Oka, A. Szuba, J. C Giacomini, and J. P Cooke
A pilot study of l-arginine supplementation on functional capacity in peripheral arterial disease
Vascular Medicine, November 1, 2005; 10(4): 265 - 274.
[Abstract] [PDF]

Home page
 Vasc MedHome page
J. Dulak, S. P Schwarzacher, R. H Zwick, H. Alber, G. Millonig, C. Weiss, H. Hugel, M. Frick, A. Jozkowicz, O. Pachinger, et al.
Effects of local gene transfer of VEGF on neointima formation after balloon injury in hypercholesterolemic rabbits
Vascular Medicine, November 1, 2005; 10(4): 285 - 291.
[Abstract] [PDF]

Home page
 Diabetes CareHome page
G. Jorneskog, M. Kalani, J. Kuhl, P. Bavenholm, A. Katz, G. Allerstrand, M. Alvarsson, S. Efendic, C.-G. Ostenson, J. Pernow, et al.
Early Microvascular Dysfunction in Healthy Normal-Weight Males With Heredity for Type 2 Diabetes
Diabetes Care, June 1, 2005; 28(6): 1495 - 1497.
[Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Rickenlund, M. J. Eriksson, K. Schenck-Gustafsson, and A. L. Hirschberg
Oral Contraceptives Improve Endothelial Function in Amenorrheic Athletes
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3162 - 3167.
[Abstract] [Full Text] [PDF]

Home page
 Vasc MedHome page
J. P Cooke
ADMA: its role in vascular disease
Vascular Medicine, May 1, 2005; 10(2_suppl): S11 - S17.
[Abstract] [PDF]

Home page
 Vasc MedHome page
K. Sydow, C. E Mondon, and J. P Cooke
Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA
Vascular Medicine, May 1, 2005; 10(2_suppl): S35 - S43.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Rickenlund, M. J. Eriksson, K. Schenck-Gustafsson, and A. L. Hirschberg
Amenorrhea in Female Athletes Is Associated with Endothelial Dysfunction and Unfavorable Lipid Profile
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1354 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. L. Bots, J. Westerink, T. J. Rabelink, and E. J.P. de Koning
Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response
Eur. Heart J., February 2, 2005; 26(4): 363 - 368.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
C. Giannattasio, A. Zoppo, G. Gentile, M. Failla, A. Capra, F.M. Maggi, A. Catapano, and G. Mancia
Acute Effect of High-Fat Meal on Endothelial Function in Moderately Dyslipidemic Subjects
Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 406 - 410.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
H. L. Gornik and M. A. Creager
Arginine and Endothelial and Vascular Health
J. Nutr., October 1, 2004; 134(10): 2880S - 2887S.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. P. Cooke
Asymmetrical Dimethylarginine: The Uber Marker?
Circulation, April 20, 2004; 109(15): 1813 - 1818.
[Full Text] [PDF]

Home page
 CirculationHome page
H. Dayoub, V. Achan, S. Adimoolam, J. Jacobi, M. C. Stuehlinger, B.-y. Wang, P. S. Tsao, M. Kimoto, P. Vallance, A. J. Patterson, et al.
Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis: Genetic and Physiological Evidence
Circulation, December 16, 2003; 108(24): 3042 - 3047.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
T.-M. Lu, Y.-A. Ding, S.-J. Lin, W.-S. Lee, and H.-C. Tai
Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention
Eur. Heart J., November 1, 2003; 24(21): 1912 - 1919.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
R. H Boger
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
Cardiovasc Res, October 1, 2003; 59(4): 824 - 833.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. C. Stuhlinger, R. K. Oka, E. E. Graf, I. Schmolzer, B. M. Upson, O. Kapoor, A. Szuba, M. R. Malinow, T. C. Wascher, O. Pachinger, et al.
Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia: Role of Asymmetric Dimethylarginine
Circulation, August 26, 2003; 108(8): 933 - 938.
[Abstract] [Full Text] [PDF]

Home page